News · 26 weeks37+67%
2026-03-012026-08-23
Mix990d
- Other3(33%)
- SEC Filings3(33%)
- Earnings2(22%)
- Insider1(11%)
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by Tactile Systems Technology Inc.SCHEDULE 13G/A - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)
- INSIDERChief Executive Officer Dodd Sheri Louise sold $323,243 worth of shares (10,978 units at $29.44), decreasing direct ownership by 5% to 232,907 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- SECSEC Form 10-Q filed by Tactile Systems Technology Inc.10-Q - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- PRTactile Systems Technology, Inc. Reports Second Quarter 2026 Financial ResultsMINNEAPOLIS, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Summary and Recent Business Highlights: Total revenue increased 9% year-over-year to $85.7 millionGross margin expanded to 76% from 75% in Q2 2025Net income increased to $7.8 million from $3.2 million in Q2 2025Adjusted EBITDA increased to $11.4 million from $7.7 million in Q2 2025Entered into an exclusive U.S. distribution agreement with ElastiMed, Inc. to distribute the MyoSleeve™
- SECTactile Systems Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- PRTactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026MINNEAPOLIS, July 21, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2026 financial results will be released after the market closes on Monday, August 10, 2026. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on August 10, 2026, to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13761142. A live webcast of the call will also be provided
- SECTactile Systems Technology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- PRTactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD PatientsMINNEAPOLIS, July 13, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced it has entered into an exclusive distribution agreement with ElastiMed, Inc. to bring MyoSleeve™, its discreet, wearable non-pneumatic compression device for the lower leg, to Department of Veterans Affairs (VA) and Department of Defense (DoD) patients across the United States. MyoSleeve expands Tactile Medical’s established market-leading portfolio by providing a new treatment option for appropriately selected patients in earlier stages of chronic swelling who ma
- PRTactile Medical Launches Next-Generation AffloVest® Airway Clearance TherapyMINNEAPOLIS, June 02, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced full commercial launch of its next-generation AffloVest high-frequency chest wall oscillation (HFCWO) therapy system. The next-generation system maintains its indication for use as a treatment option for chronic neuromuscular and respiratory conditions, including cystic fibrosis and bronchiectasis, across pediatric and geriatric populations, while introducing enhancements to patient comfort, ease of use, and connected care capabilities to support long-term therapy
- PRTactile Medical to Present at the William Blair 46th Annual Growth Stock ConferenceMINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 46th Annual Growth Stock Conference, which is being held at the Loews Hotel in Chicago, IL, from June 2-4, 2026. Management will present on Tuesday, June 2, at 9:20 a.m. Central Time. A live audio webcast of the presentation will be accessible under the "Events & Webcasts" section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for
- INSIDERCHIEF FINANCIAL OFFICER Birkemeyer Elaine M. sold $113,404 worth of shares (4,631 units at $24.49), decreasing direct ownership by 3% to 130,188 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- SECSEC Form 144 filed by Tactile Systems Technology Inc.144 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)
- INSIDERDirector Asbury Valerie L. was granted 6,521 shares, increasing direct ownership by 13% to 55,343 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Huggenberger Raymond was granted 6,521 shares, increasing direct ownership by 12% to 62,841 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector King Laura G. was granted 6,521 shares, increasing direct ownership by 34% to 25,569 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Pearson Andrea was granted 6,521 shares, increasing direct ownership by 765% to 7,373 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Shafer David Brent was granted 6,521 shares, increasing direct ownership by 13% to 55,343 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Volkart Carmen B was granted 6,521 shares, increasing direct ownership by 17% to 44,219 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Washington Boyd Vindell was granted 6,521 shares, increasing direct ownership by 19% to 41,768 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Burke William W was granted 6,521 shares, increasing direct ownership by 13% to 55,041 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- SECTactile Systems Technology Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- ANALYSTTactile Systems upgraded by B. Riley Securities with a new price targetB. Riley Securities upgraded Tactile Systems from Neutral to Buy and set a new price target of $36.00
- SECSEC Form S-8 filed by Tactile Systems Technology Inc.S-8 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- SECSEC Form 10-Q filed by Tactile Systems Technology Inc.10-Q - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- SECTactile Systems Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
TCMD FAQ
7 questionsWhat does Tactile Systems Technology Inc. do?
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; and Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.Where does TCMD stock trade?
Tactile Systems Technology Inc. (TCMD) is listed on NASDAQ.What sector and industry is TCMD in?
Tactile Systems Technology Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Tactile Systems Technology Inc. go public?
Tactile Systems Technology Inc. (TCMD) completed its IPO in 2016.What are analysts saying about TCMD?
Tactile Systems Technology Inc. has had 8 recent analyst actions on file. The most recent action was from B. Riley Securities: Buy with a $3600.00 price target on 2026-05-07. Recent price targets range from $1400.00 to $3600.00.What companies are similar to TCMD?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare TCMD side-by-side with any of them on Quantisnow.How can I track TCMD on Quantisnow?
Quantisnow aggregates Tactile Systems Technology Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TCMD to receive live email and push alerts on every new disclosure.